APA (7th ed.) Citation

Chawla, N. S., Sayegh, N., Tripathi, N., Govindarajan, A., Zengin, Z. B., Phillip, E. J., . . . Tripathi, A. (2023). Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer, 21(1), 69. https://doi.org/10.1016/j.clgc.2022.11.007

Chicago Style (17th ed.) Citation

Chawla, Neal S., et al. "Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors." Clinical Genitourinary Cancer 21, no. 1 (2023): 69. https://doi.org/10.1016/j.clgc.2022.11.007.

MLA (9th ed.) Citation

Chawla, Neal S., et al. "Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors." Clinical Genitourinary Cancer, vol. 21, no. 1, 2023, p. 69, https://doi.org/10.1016/j.clgc.2022.11.007.